Publications by authors named "Jose David Gomez-Rangel"

Claim this Profile
C
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study.
Thomas Yau, Ahmed Kaseb, Ann-Lii Cheng, Shukui Qin, Andrew X Zhu

Lancet Gastroenterol Hepatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of the proposed bevacizumab biosimilar BAT1706 compared with reference bevacizumab in patients with advanced nonsquamous non-small cell lung cancer: A randomized, double-blind, phase III study.
Likun Chen, Jose David Gomez Rangel, Timucin Cil, Xingya Li, Irfan Cicin

Cancer Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial.
Robin Kate Kelley, Lorenza Rimassa, Ann-Lii Cheng, Ahmed Kaseb, Shukui Qin

Lancet Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of acute promyelocytic leukemia: a single institution experience.
Guillermo J Ruiz-Argüelles, Amelia Morales-Toquero, José David Gómez-Rangel, Briceida López-Martínez, Guillermo J Ruiz-Delgado

Rev Invest Clin· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extramedullary leukemic relapses following hematopoietic stem cell transplantation with nonmyeloablative conditioning.
Guillermo J Ruiz-Argüelles, David Gómez-Almaguer, Jorge Vela-Ojeda, Amelia Morales-Toquero, Jóse David Gómez-Rangel

Int J Hematol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
More on geographic hematology: the breakpoint cluster regions of the PML/RARalpha fusion gene in Mexican Mestizo patients with promyelocytic leukemia are different from those in Caucasians.
Guillermo J Ruiz-Argüelles, Javier Garcés-Eisele, Virginia Reyes-Núñez, José David Gómez-Rangel, Guillermo J Ruiz-Delgado

Leuk Lymphoma· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic stem cell transplantation with non-myeloablative conditioning in patients with acute myelogenous leukemia eligible for conventional allografting: a prospective study.
Guillermo J Ruiz-Argüelles, David Gómez-Almaguer, Jose David-Gomez-Rangel, Jorge Vela-Ojeda, Olga G Cantú-Rodríguez

Leuk Lymphoma· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis